Burst Biologics
-
Biologics
Burst Biologics Initiates Prospective Multicenter Clinical Study in Spinal Fusion
March 28, 2017 BOISE, Idaho–(BUSINESS WIRE)–Burst Biologics has received IRB approval to begin a multicenter prospective clinical study in spinal…
Read More » -
Biologics
Burst Biologics: In Medical Affairs Experience Matters
25.01.2017 / BY HAYLEY PARONISH Expressing his eagerness to expand into the growing area of stem cell research and regenerative…
Read More »